|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.900 SEK | +12.93% |
|
+18.97% | +23.21% |
| 06-24 | Mendus to issue shares for compensation | FW |
| 06-18 | Mendus CEO Erik Manting purchases shares worth nearly SEK 1m | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 38.86M | - | ||||
| 49.92B | |||||
| 40.23B | - | - | - | - | - |
| 34.55B | |||||
| 33.09B | |||||
| 27.51B |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
